# Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects

> **NCT00977951** · PHASE1,PHASE2 · COMPLETED · sponsor: **Renovo** · enrollment: 20 (actual)

## Conditions studied

- Cicatrix
- Wound Healing

## Interventions

- **DRUG:** Intradermal avotermin
- **DRUG:** Intradermal avotermin
- **DRUG:** Placebo (vehicle)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00977951
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977951, "Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00977951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*